Gallery
- PM Modi visit USAOnly the mirror in my washroom and phone gallery see the crazy me : Sara KhanKarnataka rain fury: Photos of flooded streets, uprooted treesCannes 2022: Deepika Padukone stuns at the French Riviera in Sabyasachi outfitRanbir Kapoor And Alia Bhatt's Wedding Pics - Sealed With A KissOscars 2022: Every Academy Award WinnerShane Warne (1969-2022): Australian cricket legend's life in picturesPhotos: What Russia's invasion of Ukraine looks like on the groundLata Mangeshkar (1929-2022): A pictorial tribute to the 'Nightingale of India'PM Modi unveils 216-feet tall Statue of Equality in Hyderabad (PHOTOS)
Jakub Mensik overcame rain and an opponent chasing history when he stunned six-time champi
- KIPG: Son of a vegetable vendor, Bihar’s Jhandu Kumar eyes Worlds, 2028 Paralympics
- Hardik Singh credits hard work and team unity for receiving HI Midfielder of the Year award
- Djokovic, Alcaraz land in same half of Miami draw
- India to host 2nd Asian Yogasana Championships from March 29 to 31
- FA Cup: AFC Bournemouth secure 5-4 penalty shootout win vs Wolves to reach QF
ICMR chief admitted to AIIMS after testing Covid positive Last Updated : 18 Dec 2020 07:11:36 PM IST ICMR Director General Balram Bhargava Indian Council of Medical Research (ICMR) Director General Balram Bhargava has been admitted to the All India Institute of Medical Sciences (AIIMS) after he tested positive for Covid-19.
The 59-year-old ICMR chief was admitted to AIIMS's Trauma Centre, a dedicated Covid-19 facility, on December 16, a hospital source told IANS on condition of anonymity.Bhargava heads the apex medical body which is responsible for formulation, coordination and promotion of biomedical research in India. It is at the forefront of the Covid-19 outbreak management in the country.Bhargava is on a three-year deputation as the Director-General of ICMR. He is also the Secretary of the Department of Health Research, a division under the Union Ministry of Health and Family Welfare.
IANS New Delhi For Latest Updates Please-
Join us on
Follow us on
172.31.16.186